SEC Form 4 · accession 0001127602-15-009259
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marviette D. Johnson
Officer — VP, Human Resources
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 9:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2015 | S | 1,917 | $19.911 | D | 46,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prices range from $19.91 per share to $19.92 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.